CPB vs DEO Stock Comparison
Compare CPB and DEO across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between CPB and DEO?
CPB leads the current stock comparison as Campbell Soup Company, with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Campbell Soup Company vs Diageo plc
CPB leads
CPB leads by 2 AIQ points, primarily on Value. Wall Street currently favors DEO on target upside.
Fragile: 1 of 6 evidence groups support CPB, and its current signal state is conflicted.
Campbell Soup Company
Diageo plc
The Algovestiq AIQ Score currently favors CPB over DEO, 40 versus 38 as of Sep 11, 2026. CPB's advantage is driven primarily by stronger value, while DEO holds the stronger risk resilience profile. CPB also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors DEO. 1 of 6 covered evidence groups favor CPB today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. CPB lead: Stable — the AIQ differential has held near 2 points over 30 sessions.
Compare Campbell Soup Company and Diageo plc across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare CPB and DEO against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value67 vs 37CPB +30
- Risk Resilience26 vs 51DEO +25
- Quality32 vs 42DEO +10
- Momentum24 vs 28DEO +4
1 of 6 evidence groups favor CPB. CPB’s edge is concentrated in value; DEO keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Risk Resilience -2
New signals
- BB Lower Band Breach — bullish, volatility, short horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
No factor moved materially.
New signals
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
CPB's lead was unchanged in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — CPB and DEO both carry a full feed there.
The central trade-off
CPB (Campbell Soup Company): the stronger current systematic profile, led by value.
DEO (Diageo plc): the counter-case, on risk resilience, quality, momentum.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CPBCPB on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CPBCPB on combined revenue and EPS growth.
Value
CPBCPB on the peer-relative Value factor, by 30 points.
Momentum
DEODEO on the Momentum factor, by 4 points.
Lower downside
DEODEO on Risk Resilience, by 25 points.
Analyst upside
DEODEO on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CPB, analyst targets favor DEO. That disagreement is the most useful thing on this page.
| Measure | CPB | DEO | Note |
|---|---|---|---|
| Implied upside to target | -5.9% | +14.3% | DEO has more room |
| Target dispersion | +30.4% | 0% | Lower is tighter analyst agreement |
| Consensus | Hold | Hold | Context, not a primary driver |
| Analysts covering | 13 | 1 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
1 of 6 covered evidence groups favor CPB. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 40 vs 38 |
| Fundamentals | Even | revenue growth -7.7% vs -11.8%; EPS growth -14.3% vs -112.4%; TTM ROE 15.3% vs 15.5%; gross margin 28.8% vs 59.5%; operating margin 11.5% vs 28.4% |
| Valuation | CPB | Value 67 vs 37 |
| Technicals | DEO | Price vs 50-day -7.3% vs -2%; vs 200-day -12.6% vs 0.7% |
| Risk Resilience | DEO | Risk Resilience 26 vs 51 |
| Analyst expectations | DEO | Target upside -5.9% vs 14.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CPB and DEO and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
- Only 1 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CPB.
How the comparison changed
119 daily snapshots · May 4 – Sep 10CPB lead: Stable — the AIQ differential has held near 2 points over 30 sessions.
- Today
- CPB +2
- 40 vs 38
- 7 sessions ago
- DEO +3
- 41 vs 44
- 30 sessions ago
- CPB +4
- 52 vs 48
- 90 sessions ago
- CPB +3
- 49 vs 46
The lead changed hands 11 times in this window, most recently on Sep 8 when CPB moved ahead of DEO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 4 bearish / 2 neutral, conflicted
- Death Cross Active — bearish, trend, long horizon (5.81%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- BB Lower Band Breach — bullish, volatility, short horizon
2 bullish / 2 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (3.11%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
CPB leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.29%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.37%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DEO closes the Value gap — currently 30 points behind, the largest single contributor to CPB's edge.
- 2DEO's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
- 3CPB's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | CPB | DEO |
|---|---|---|
| Revenue growth (YoY) | -7.7% | -11.8% |
| EPS growth (YoY) | -14.3% | -112.4% |
| Gross margin | 28.8% | 59.5% |
| Operating margin | 11.5% | 28.4% |
| Return on equity (TTM) | 15.3% | 15.5% |
| Debt to equity | 1.74 | 2.03 |
Performance
DEO leads 5 of 6 windows| Metric | CPB | DEO |
|---|---|---|
| 1 week (5 sessions) | -11.9% | -5.3% |
| 1 month (20 sessions) | -7.3% | -8.1% |
| 3 months (63 sessions) | -8.5% | 8.2% |
| 6 months (126 sessions) | -8.7% | 8.3% |
| Year to date | -24.9% | 0% |
| 1 year (252 sessions) | -37.3% | -18.9% |
Technicals
DEO has the stronger structure| Metric | CPB | DEO |
|---|---|---|
| RSI (14) | 25.2 | 27 |
| ADX (14) | 24.6 | 18 |
| Price vs 50-day | -7.3% | -2% |
| Price vs 200-day | -12.6% | 0.7% |
| Volatility (1M, annualized) | 40.5% | 24.5% |
Risk
DEO is the more resilient| Metric | CPB | DEO |
|---|---|---|
| Beta | -0.28 | 0.26 |
| Sharpe ratio | -1.47 | -0.54 |
| Sortino ratio | -2 | -0.71 |
| Max drawdown | -40.8% | -31% |
| Current drawdown | -38% | -17.8% |
| Annualized volatility | 31.8% | 33.1% |
| Value at risk (95%) | -3.6% | -2.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CPB or DEO?
On the Algovestiq AIQ Score, CPB is the stronger of the two as of Sep 11, 2026, scoring 40 against DEO's 38. The edge comes from value. DEO is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CPB or DEO the better buy right now?
CPB carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 1 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.
Why does the AIQ Score favor CPB over DEO?
The composite weights Quality, Value, Momentum and Risk Resilience. CPB leads Value by 30 points; DEO leads Risk Resilience by 25 points; DEO leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CPB or DEO?
Analyst price targets imply -5.9% upside for CPB and +14.3% for DEO, so the Street currently favors DEO. That points the opposite way to the AIQ Score, which favors CPB. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CPB or DEO?
CPB is the better-valued of the two on the peer-relative Value factor. CPB on the peer-relative Value factor, by 30 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CPB or DEO?
CPB on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CPB or DEO?
DEO on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CPB or DEO?
DEO is the more resilient of the two, so the other name carries the higher downside risk. DEO on Risk Resilience, by 25 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CPB more profitable than DEO?
DEO leads on the comparable margin measures — gross margin 28.8% vs 59.5%; operating margin 11.5% vs 28.4%; ttm roe 15.3% vs 15.5%.
Is CPB's lead over DEO getting stronger or weaker?
CPB lead: Stable — the AIQ differential has held near 2 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 11 times in that window, most recently on 2026-09-08, when CPB moved ahead of DEO.
What would change the CPB vs DEO verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DEO closes the Value gap — currently 30 points behind, the largest single contributor to CPB's edge; DEO's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; CPB's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about CPB and DEO?
CPB: 2 bullish / 4 bearish / 2 neutral, conflicted. DEO: 2 bullish / 2 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CPB is Death Cross Active (bearish, long horizon). On DEO it is Golden Cross Active (bullish, long horizon).
Compare CPB and DEO with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.